Jeff Millan

Title: Jeff Millan - Innovator in Therapeutic Formulations

Introduction

Jeff Millan is a notable inventor based in Bend, OR (US). He has made significant contributions to the field of therapeutic formulations, particularly in the treatment of central nervous system diseases. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Jeff Millan holds a patent for "Therapeutic formulations and uses thereof." This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor with non-sedative anxiolytic effects. Specifically, it involves solid dispersions, methods of manufacture, and therapeutic methods and uses in treating diseases of the central nervous system. This patent highlights his commitment to advancing medical science and providing new solutions for patients.

Career Highlights

Throughout his career, Jeff has been associated with Bionomics Inc., where he has played a crucial role in research and development. His work has not only contributed to the company's success but has also positioned him as a key figure in the field of therapeutic innovations. His dedication to his craft is evident in the quality and impact of his inventions.

Collaborations

Jeff Millan has collaborated with talented individuals such as Dharam Paul and Julia Crossman. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in therapeutic formulations.

Conclusion

In summary, Jeff Millan is a distinguished inventor whose work in therapeutic formulations has the potential to transform the treatment of central nervous system diseases. His patent and collaborations reflect his commitment to innovation and improving health outcomes for patients.